These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
923 related items for PubMed ID: 17126889
1. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study. Oger E, Lacut K, Le Gal G, Couturaud F, Abalain JH, Mercier B, Mottier D, EDITH (Etude des Déterminants/Interaction de la THrombose veineuse) Collaborative Study Group. Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889 [Abstract] [Full Text] [Related]
2. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F. Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134 [Abstract] [Full Text] [Related]
3. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population. Adamczuk Y, Iglesias Varela ML, Forastiero R, Martinuzzo M, Cerrato G, Pombo G, Carreras LO. Thromb Haemost; 2000 Mar; 83(3):509-10. PubMed ID: 10744162 [No Abstract] [Full Text] [Related]
4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL. Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [Abstract] [Full Text] [Related]
5. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism. De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G. Semin Thromb Hemost; 2000 Sep; 26(3):305-11. PubMed ID: 11011848 [Abstract] [Full Text] [Related]
8. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene. De Stefano V, Rossi E, Paciaroni K, D'Orazio A, Cina G, Marchitelli E, Pepe R, Leone G. Haematologica; 2003 Jan; 88(1):61-6. PubMed ID: 12551828 [Abstract] [Full Text] [Related]
11. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G. N Engl J Med; 1999 Sep 09; 341(11):801-6. PubMed ID: 10477778 [Abstract] [Full Text] [Related]
16. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study. Chaireti R, Jennersjö C, Lindahl TL. Thromb Res; 2009 Jun 09; 124(2):178-84. PubMed ID: 19232683 [Abstract] [Full Text] [Related]
19. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group. Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339 [Abstract] [Full Text] [Related]